Health Affairs, 24, no. 1 (2005): 52-54 doi: 10.1377/hlthaff.24.1.52 © 2005 by Project HOPE	New Online   New Issue: China & India   Obesity In China   Pay Cuts For Medicare Docs   Access To Care Woes

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Stanton, M. S. Search for Related Content PubMed PubMed Citation Articles by Stanton, M. S. Related Collections Evidence-Based Medicine Health Reform Medicare Physicians Quality Of Care Research And Technology Politics

Case Studies

PERSPECTIVE

Implantable Cardioverter Defibrillators: An Excellent Case Study

Numerous randomized controlled trials have shown that implantable cardioverter defibrillators (ICDs) reduce mortality from sudden cardiac death. Evidence-based medicine can elucidate the benefits of treatment and inform Medicare policy when applied in a consistent and nonselective manner. The use of cost-effectiveness data to determine Medicare coverage—and therefore access to a therapy—involves many practical challenges. Cost-effectiveness analysis may be more useful as a tool to guide marketplace decision making than as a regulatory mechanism. Medicare coverage does not mandate use of a therapy; it allows the discussion to occur between a patient and his or her doctor.

                      What's this?

This article has been cited by other articles:

				P. J. Neumann, A. B. Rosen, and M. C. Weinstein Medicare and Cost-Effectiveness Analysis N. Engl. J. Med., October 6, 2005; 353(14): 1516 - 1522. [Full Text] [PDF]